(Q34167104)

31 July 2017

1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats (English)

1 reference

31 July 2017

L E Schechter

1

1 reference

PubMed ID

3128809

31 July 2017

K J Simansky

series ordinal

2

1 reference

31 July 2017

1 January 1988

1 reference

31 July 2017

1 reference

31 July 2017

94

1 reference

31 July 2017

3

1 reference

31 July 2017

342-346

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00174687

31 July 2017

0 references

cites work

Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).

1 reference

12 December 2020

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

1 reference

12 December 2020

1 reference

12 December 2020

Weight gain. A side-effect of tricyclic antidepressants

1 reference

12 December 2020

Effects of chronic amitriptyline and desipramine on food intake and body weight in rats

1 reference

12 December 2020

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

1 reference

12 December 2020

Serotonin receptor sensitivity after acute and chronic treatment with mianserin.

1 reference

12 December 2020

Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats

1 reference

12 December 2020

Neurotransmitter basis of the behavioral effects of hallucinogens.

1 reference

12 December 2020

8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.

1 reference

12 December 2020

Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats

1 reference

12 December 2020

Is there a role for serotonin (5-hydroxytryptamine) in feeding?

1 reference

12 December 2020

Effect of the 5HT2 antagonist ritanserin on food intake and on 5HT-induced anorexia in the rat.

1 reference

12 December 2020

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

12 December 2020

Dissociation of the anorectic actions of 5-HTP and fenfluramine

1 reference

12 December 2020

The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.

1 reference

12 December 2020

LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat

1 reference

12 December 2020

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

1 reference

12 December 2020

Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat

1 reference

12 December 2020

5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

1 reference

12 December 2020

Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat

1 reference

12 December 2020

Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.

1 reference

12 December 2020

Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine

1 reference

12 December 2020

Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat.

1 reference

12 December 2020

Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents

1 reference

12 December 2020

Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors

1 reference

12 December 2020

The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats.

1 reference

12 December 2020

Comparison of anorexia and motor disruption by cyclazocine and quipazine.

1 reference

12 December 2020

Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane

1 reference

12 December 2020

New Peripheral Antagonists of 5-Hydroxytryptamine

1 reference

12 December 2020

Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex

1 reference

12 December 2020

Brain serotonin and eating behavior

1 reference

12 December 2020

Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin

1 reference

12 December 2020

Unusual appetites in patients on mianserin

1 reference

12 December 2020

Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.

1 reference

12 December 2020

Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.

1 reference

12 December 2020

Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle

1 reference

12 December 2020

A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212)

1 reference

12 December 2020

5-HT1 and 5-HT2 binding characteristics of some quipazine analogues

1 reference

12 December 2020

Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00174687

1 reference

PubMed ID

3128809

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

3128809